Prof Bryan Williams

Prof Bryan WilliamsTel: 020 3447 9910
Email: bryan.williams@ucl.ac.uk

Location:
University College Hospital

Specialities:
General Medicine

Professional background

Clinical appointments and enquiries:
Helen McCabe 
Telephone: 020 3447 9910

PA at UCL/BRC:
Margaret Norton
Telephone: 020 7679 6639

Bryan Williams is Chair of Medicine at University College London and Director of the NIHR UCLH/UCL Biomedical Research Centre and Director of Research at UCL Hospitals. He is a Consultant Physician at UCL Hospitals and a NIHR Senior Investigator. He is Chairman-Elect of the European Council on Hypertension of the European Society of Cardiology.

Professor Williams research and clinical practice is in the field of high blood pressure (hypertension) in which he is recognised as one of the world's leading authorities. He has a particular interest in complex and difficult to control blood pressure and high blood pressure in young people.           

Professor Williams is the Past President of the British Hypertension Society (2001–2003) and is Chairman of the NICE Hypertension Guidelines Development Group (2011), Chairman of the NICE Hypertension National Quality Standards development group (2013) and Chairman of the NICE Evidence Update for Hypertension report (2013).  He is a member of national and international hypertension societies and a Fellow of the American Heart Association, the European Society of Cardiology and the Royal College of Physicians, London.

Research interests

High blood pressure, Cardiovascular disease and development of new treatments and methods for patient monitoring. 

Publications

1.            Mancia, G., Mahfoud, F., Narkiewicz, K., Ruilope, L. M., Schlaich, M. P., Schmieder, R. E., . . . Böhm, M. (2015). 4A.01: LONG-TERM EFFECTS OF RENAL ARTERY DENERVATION IN REAL WORLD PATIENTS WITH UNCONTROLLED HYPERTENSION FROM THE GLOBAL SYMPLICITY REGISTRY. Journal of hypertension, 33 Suppl 1, e49-?. doi:10.1097/01.hjh.0000467475.67073.7e

2.            Mahfoud, F., Linz, D., Mancia, G., Narkiewicz, K., Ruilope, L. M., Schlaich, M. P., . . . Böhm, M. (2015). 8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY. Journal of hypertension, 33 Suppl 1, e108-?. doi:10.1097/01.hjh.0000467640.39623.b2
3.            Brown, M. J., Williams, B., MacDonald, T. M., Caulfield, M., Cruickshank, J. K., McInnes, G., . . . Ford, I. (2015). Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. BMJ open, 5 (8), e008086-?. doi:10.1136/bmjopen-2015-008086
4.            Lacy, P. S., Brunel, P., Bader, G., Jones, A., Baschiera, F., Düsing, R., & Williams, B. (2015). Effects of treatment withdrawal on brachial and central aortic pressure after direct renin inhibition or angiotensin receptor blockade. Journal of the renin-angiotensin-aldosterone system : JRAAS. doi:10.1177/1470320315579592
5.            Hudson, L. D., Viner, R. M., Rapala, A., Khan, T., & Williams, B. (2015). Evidence for contemporary arterial stiffening in obese children and adolescents using pulse wave velocity: A systematic review and meta-analysis. Atherosclerosis, 241 (2), 376-386. doi:10.1016/j.atherosclerosis.2015.05.014
6.            Böhm, M., Mahfoud, F., Ukena, C., Hoppe, U. C., Narkiewicz, K., Negoita, M., . . . Mancia, G. (2015). First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension, 65 (4), 766-774. doi:10.1161/HYPERTENSIONAHA.114.05010
7.            Lobo, M. D., de Belder, M. A., Cleveland, T., Collier, D., Dasgupta, I., Deanfield, J., . . . Renal Association. (2015). Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. Heart, 101 (1), 10-16. doi:10.1136/heartjnl-2014-307029
8.            MacDonald, T. M., Williams, B., Caulfield, M., Cruickshank, J. K., McInnes, G., Sever, P., . . . Brown, M. J. (2015). Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial. BMJ open, 5 (8), e007645-?. doi:10.1136/bmjopen-2015-007645
9.            Bray, E. P., Jones, M. I., Banting, M., Greenfield, S., Hobbs, F. D., Little, P., . . . Mcmanus, R. J. (2015). Performance and persistence of a blood pressure self-management intervention: telemonitoring and self-management in hypertension (TASMINH2) trial. J Hum Hypertens, 29 (7), 436-441. doi:10.1038/jhh.2014.108
10.         Williams, B., MacDonald, T. M., Caulfield, M., Cruickshank, J. K., McInnes, G., Sever, P., . . . Brown, M. J. (2015). Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension. BMJ open, 5 (8), e008951-?. doi:10.1136/bmjopen-2015-008951
11.         Thomas, M. C., Woodward, M., Neal, B., Li, Q., Pickering, R., Marre, M., . . . Hillis, G. S. (2015). The Relationship Between Levels of Advanced Glycation End-Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes. Diabetes care.
12.         Williams, B. (2015). Treating hypertension in patients with diabetes: When to start and how low to go?. JAMA - Journal of the American Medical Association, 313 (6), 573-574.
13.         Rapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Shah, A. D., Denaxas, S., . . . Hemingway, H. (2014). Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1•25 million people. Lancet, 383 (9932), 1899-1911. doi:10.1016/S0140-6736(14)60685-1
14.         Rapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Denaxas, S., Shah, A. D., . . . Hemingway, H. (2014). Blood pressure and incidence of twelve cardiovascular diseases; lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. EUROPEAN HEART JOURNAL, 35, 1082.
15.         Welsh, P., Woodward, M., Hillis, G. S., Li, Q., Marre, M., Williams, B., . . . Sattar, N. (2014). Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial. Diabetes Care, 37 (8), 2202-2210. doi:10.2337/dc13-2625
16.         McManus, R. J., Mant, J., Haque, M. S., Bray, E. P., Bryan, S., Greenfield, S. M., . . . Buckley, D. (2014). Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA, 312 (8), 799-808. doi:10.1001/jama.2014.10057
17.         Chalmers, J., Arima, H., Woodward, M., Zoungas, S., Patel, A., Hirakawa, Y., . . . Harrap, S. (2014). Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: Results from the action in diabetes and vascular disease: Preterax and diamicron controlled evaluation (ADVANCE) trial. Hypertension, 63 (2), 259-264. doi:10.1161/HYPERTENSIONAHA.113.02252
18.         Lacy, P. S., Brunel, P., Baschiera, F., Botha, J., & Williams, B. (2014). Effects of exercise on central aortic pressure before and after treatment with renin-angiotensin system blockade in patients with hypertension. J Renin Angiotensin Aldosterone Syst. doi:10.1177/1470320314538879
19.         van Dieren, S., Kengne, A. P., Chalmers, J., Beulens, J. W. J., Davis, T. M. E., Fulcher, G., . . . Zoungas, S. (2014). Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension. DIABETES OBESITY & METABOLISM, 16 (5), 426-432. doi:10.1111/dom.12235
20.         Davies, J. E., Lacy, P., Tillin, T., Collier, D., Cruickshank, J. K., Francis, D. P., . . . Hughes, A. D. (2014). Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes Trial. Hypertension, 64 (1), 60-68. doi:10.1161/HYPERTENSIONAHA.113.02838
21.         Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., . . . Biostat, M. (2014). Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal of Medicine, 371 (15), 1392-1406. doi:10.1056/NEJMoa1407963
22.         Banegas, J. R., Ruilope, L. M., de la Sierra, A., de la Cruz, J. J., Gorostidi, M., Segura, J., . . . Williams, B. (2014). High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J, 35 (46), 3304-3312. doi:10.1093/eurheartj/ehu016
23.         Tomaszewski, M., White, C., Patel, P., Masca, N., Damani, R., Hepworth, J., . . . Williams, B. (2014). High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart, 100 (11), 855-861. doi:10.1136/heartjnl-2013-305063
24.         Hodgkinson, J., Grant, S., Bray, E., Stevens, S., Martin, U., Perera-Salazar, R., . . . McManus, R. (2014). Home Blood Pressure Monitoring - what is the optimal schedule? A systematic review. JOURNAL OF HUMAN HYPERTENSION, 28 (10), 633-634.
25.         Zoungas, S., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., . . . Grp, A. D. V. A. N. C. E. C. (2014). Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. DIABETOLOGIA, 57 (12), 2465-2474. doi:10.1007/s00125-014-3369-7
26.         Zoungas, S., Woodward, M., Li, Q., Patel, A., Chalmers, J., Cooper, M. E., . . . Williams, B. (2014). Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia, 57 (12), 2465-2474. doi:10.1007/s00125-014-3369-7
27.         van Dieren, S., Kengne, A. P., Chalmers, J., Patel, A., Neal, B., Woodward, M., . . . Williams, B. (2014). Intensification of medication and glycaemic control among patients with type 2 diabetes-The ADVANCE trial. Diabetes, Obesity and Metabolism, 16 (5), 426-432. doi:10.1111/dom.12238
28.         Sheppard, J. P., Holder, R., Nichols, L., Bray, E., Hobbs, F. D., Mant, J., . . . McManus, R. J. (2014). Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study. J Hypertens, 32 (11), 2171-2178. doi:10.1097/HJH.0000000000000319
29.         Williams, B., Cockcroft, J. R., Kario, K., Zappe, D. H., Cardenas, P., Hester, A., . . . Zhang, J. (2014). Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study. BMJ Open, 4 (2), e004254-?. doi:10.1136/bmjopen-2013-004254
30.         Kaambwa, B., Bryan, S., Jowett, S., Mant, J., Bray, E. P., Hobbs, F. D., . . . McManus, R. J. (2014). Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol, 21 (12), 1517-1530. doi:10.1177/2047487313501886
31.         Blomster, J. I., Zoungas, S., Chalmers, J., Li, Q., Chow, C. K., Woodward, M., . . . Hillis, G. S. (2014). The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. DIABETES CARE, 37 (5), 1353-1359. doi:10.2337/dc13-2727
32.         Hillis, G. S., Welsh, P., Chalmers, J., Perkovic, V., Chow, C. K., Li, Q., . . . Woodward, M. (2014). The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. DIABETES CARE, 37 (1), 295-303. doi:10.2337/dc13-1165
33.         Kjeldsen, S., Feldman, R. D., Lisheng, L., Mourad, J. -. J., Chiang, C. -. E., Zhang, W., . . . Williams, B. (2014). Updated National and International Hypertension Guidelines: A Review of Current Recommendations. DRUGS, 74 (17), 2033-2051. doi:10.1007/s40265-014-0306-5
34.         Theilade, S., Lajer, M., Hansen, T. W., Joergensen, C., Persson, F., Andrésdottir, G., . . . Williams, B. (2013). 24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study. Cardiovascular Diabetology, 12 (1). doi:10.1186/1475-2840-12-122
35.         Williams, B. (2013). Blood pressure and diabetes: a fatal attraction. Eur Heart J, 34 (44), 3395-3397. doi:10.1093/eurheartj/eht365
36.         Williams, B., Baschiera, F., Lacy, P. S., Botha, J., Prescott, M. F., & Brunel, P. (2013). Blood pressure and plasma renin activity responses to different strategies to inhibit the renin-angiotensin-aldosterone system during exercise. J Renin Angiotensin Aldosterone Syst, 14 (1), 56-66. doi:10.1177/1470320312454766
37.         Wong, M. G., Yaghobian Azari, D., Pollock, C. A., Perkovic, V., Woodward, M., Chalmers, J., . . . Cooper, M. (2013). Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney International, 83 (2), 278-284. doi:10.1038/ki.2012.383
38.         Mahfoud, F., Mancia, G., Schlaich, M. P., Narkiewicz, K., Ruilope, L., Williams, B., . . . Bohm, M. (2013). Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62 (18), B19-B20.
39.         Komori, T., Eguchi, K., Hoshide, S., Williams, B., & Kario, K. (2013). Comparison of wrist-type and arm-type 24-h blood pressure monitoring devices for ambulatory use. Blood Press Monit, 18 (1), 57-62. doi:10.1097/MBP.0b013e32835d124f
40.         Nicholls, S. J., Kataoka, Y., Bakris, G. L., Kastelein, J. J. P., Menon, V., Nissen, S. E., . . . Fang, H. (2013). Effect of aliskiren on progression of coronary disease in patients with prehypertension: The AQUARIUS randomized clinical trial. JAMA - Journal of the American Medical Association, 310 (11), 1135-1144. doi:10.1001/jama.2013.277169
41.         Hata, J., Arima, H., Rothwell, P. M., Woodward, M., Zoungas, S., Anderson, C., . . . ADVANCE Collaborative Group. (2013). Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation, 128 (12), 1325-1334. doi:10.1161/CIRCULATIONAHA.113.002717
42.         Mahfoud, F., Böhm, M., Lüscher, T. F., Andersson, B., Baumgartner, I., Cifkova, R., . . . Zeller, T. (2013). Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. European Heart Journal, 34 (28), 2149-2157. doi:10.1093/eurheartj/eht154
43.         Hillis, G. S., Welsh, P., Chalmers, J., Chow, C. K., Perkovic, V., Poulter, N., . . . Woodward, M. (2013). High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus. EUROPEAN HEART JOURNAL, 34, 301.
44.         Tomaszewski, M., Williams, B., & Musameh, M. D. (2013). Hypertension - A clinical update for physicians. Clinical Medicine, Journal of the Royal College of Physicians of London, 13 (2), 182-184. doi:10.7861/clinmedicine.13-2-182
45.         Musameh, M. D., Tomaszewski, M., & Williams, B. (2013). Hypertension - a clinical update for physicians. Clin Med, 13 (2), 182-184. doi:10.7861/clinmedicine.13-2-182
46.         van Dieren, S., Kengne, A. P., Chalmers, J., Patel, A., Neal, B., Woodward, M., . . . Williams, B. (2013). Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial. Diabetes, Obesity and Metabolism. doi:10.1111/dom.12238
47.         Schlaich, M. P., Hering, D., Esler, M. D., Schmieder, R. E., Bakris, G., Blankestijn, P. J., . . . Zeller, T. (2013). International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. Journal of the American College of Cardiology, 62 (22), 2031-2045. doi:10.1016/j.jacc.2013.08.1616
48.         Williams, B., Lacy, P. S., Baschiera, F., Brunel, P., & Düsing, R. (2013). Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study. Hypertension, 61 (6), 1168-1176. doi:10.1161/HYPERTENSIONAHA.111.00763
49.         Jones, M. I., Holder, R., McManus, R. J., Little, P., Mant, J., Williams, B., . . . Hobbs, F. D. R. (2013). Patient self-monitoring of blood pressure and self-titration of medication in primary care: The TASMINH2 trial qualitative study of health professionals' experiences. British Journal of General Practice, 63 (611). doi:10.3399/bjgp13X668168
50.         Newman, J. E., Bown, M. J., Sayers, R. D., Thompson, J. P., Robinson, T. G., Williams, B., . . . Naylor, A. R. (2013). Poorly controlled BP and impaired baroreceptor function (but not impaired autoregulation) are associated with a significantly higher prevalence of post-carotid endarterectomy hypertension. BRITISH JOURNAL OF SURGERY, 100, 12.
51.         Böhm, M., Mahfoud, F., Ukena, C., Bauer, A., Fleck, E., Hoppe, U. C., . . . Mancia, G. (2013). Rationale and design of a large registry on renal denervation: The Global SYMPLICITY registry. EuroIntervention, 9 (4), 484-492. doi:10.4244/EIJV9I4A78
52.         Myat, A., Redwood, S. R., Qureshi, A. C., Thackray, S., Cleland, J. G. F., Bhatt, D. L., . . . Gersh, B. J. (2013). Renal sympathetic denervation therapy for resistant hypertension a contemporary synopsis and future implications. Circulation: Cardiovascular Interventions, 6 (2), 184-197. doi:10.1161/CIRCINTERVENTIONS.112.000037
53.         McManus, R. J., Mant, J., Haque, M. S., Bray, E. P., Greenfield, S., Jones, M. I., . . . Hobbs, F. D. R. (2013). Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): a randomised controlled trial. JOURNAL OF HUMAN HYPERTENSION, 27 (10), 643.
54.         O'Brien, C., Bray, E. P., Greenfield, S. M., Haque, M. S., Jones, M. I., Schwartz, C., . . . Williams, B. (2013). Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): Protocol for a randomised controlled trial. BMC Cardiovascular Disorders, 13. doi:10.1186/1471-2261-13-21
55.         Boehm, M., Schlaich, M., Narkiewicz, K., Ruilope, L., Williams, B., Schmieder, R., . . . Mancia, G. (2013). The blood pressure lowering effects of renal denervation in a real world population of patients with uncontrolled hypertension: early outcomes from the Global SYMPLICITY registry. EUROPEAN HEART JOURNAL, 34, 673-674.
56.         Lajer, M., Theilade, S., Joergensen, C., Persson, F., Andresdottir, G., Nielsen, S., . . . Rossing, P. (2012). Bone mineral density, kidney function and arterial stiffness in long-standing type 1 diabetic patients with or without diabetic nephropathy. DIABETOLOGIA, 55, S467-S468.
57.         Williams, B., & Lacy, P. S. (2012). Central aortic pressure: The next frontier in blood pressure measurement?. Special Issues in Hypertension, 181-197. doi:10.1007/978-88-470-2601-8_15
58.         Webb, D. R., Khunti, K., Lacy, P., Gray, L. J., Mostafa, S., Talbot, D., . . . Davies, M. J. (2012). Conduit vessel stiffness in British south Asians of Indian descent relates to 25-hydroxyvitamin D status. J Hypertens, 30 (8), 1588-1596. doi:10.1097/HJH.0b013e328354f385
59.         McManus, R. J., Heneghan, C., Hobbs, F. R., Lovibond, K., & Williams, B. (2012). Cost-effectiveness of diagnosis of high blood pressure in primary care - Authors' reply. The Lancet, 379 (9817), 710. doi:10.1016/S0140-6736(12)60303-1
60.         Williams, B. (2012). Evaluating interventions to reduce central aortic pressure, arterial stiffness and morbidity-mortality. JOURNAL OF HYPERTENSION, 30, S13-S18. doi:10.1097/HJH.0b013e328353e523
61.         Theilade, S., Lajer, M., Joergensen, C., Persson, F., Andresdottir, G., Reinhard, H., . . . Rossing, P. (2012). First ever 24-hour central blood pressure in patients with type 1 diabetes. DIABETOLOGIA, 55, S504.
62.         McManus, R., Caulfield, M., & Williams, B. (2012). NICE hypertension guideline 2011: Evidence based evolution. BMJ (Online), 344 (7841). doi:10.1136/bmj.e181
63.         Jones, M. I., Greenfield, S. M., Bray, E. P., Baral-Grant, S., Holder, R., Virdee, S. K., . . . Williams, B. (2012). Patients' experiences of self-monitoring blood pressure and self-titration ofmedication: The TASMINH2 trial qualitative study. British Journal of General Practice, 62 (595). doi:10.3399/bjgp12X625201
64.         Brown, M., Caulfield, M., Cruickshank, K., MacDonald, T., McInnes, G., Sever, P., . . . Ford, I. (2012). Proportion of patients with previously uncontrolled hypertension who achieve target blood pressure through participation in the BHS's prevention and treatment of hypertension with algorithm based therapy (PATHWAY) trials. JOURNAL OF HUMAN HYPERTENSION, 26 (10), 625.
65.         Myat, A., Redwood, S. R., Qureshi, A. C., Spertus Director, J. A., & Williams, B. (2012). Resistant hypertension. BMJ (Online), 345 (7884). doi:10.1136/bmj.e7473
66.         Hillis, G. S., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C. K., . . . Chalmers, J. (2012). Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 1 (5), UNSP e002832. doi:10.1161/JAHA.112.002832
67.         Redon, J., Mancia, G., Sleight, P., Williams, B., Schumacher, H., Böhm, M., . . . Yusoff, K. (2012). Safety and efficacy of low blood pressures among patients with diabetes: Subgroup analyses from the ontarget (ongoing telmisartan alone and in combination with ramipril global endpoint trial). Journal of the American College of Cardiology, 59 (1), 74-83. doi:10.1016/j.jacc.2011.09.040
68.         Tomaszewski, M., Williams, B., & Samani, N. J. (2012). The John Swales Lecture: a new initiative to honour the founding editor of the Journal of Hypertension. J Hypertens, 30 (11), 2059-?. doi:10.1097/HJH.0b013e328357f1ac
69.         Wong, G., Craig, J. C., Howard, K., Chapman, J. R., Zoungas, S., Lo, S., . . . Williams, B. (2012). The risk of cancer in people with diabetes and chronic kidney disease. Nephrology Dialysis Transplantation, 27 (8), 3337-3344. doi:10.1093/ndt/gfs022
70.         Parthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., . . . MacDonald, T. M. (2011). A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. Journal of Hypertension, 29 (5), 980-990. doi:10.1097/HJH.0b013e3283455ca5
71.         Williams, B., Krause, T., Lovibond, K., Caulfield, M., & McCormack, T. (2011). Authors' reply to Harding and colleagues, Taylor, Cruickshank, and El Turabi and Payne. BMJ (Online), 343 (7827). doi:10.1136/bmj.d6506
72.         Lovibond, K., Wonderling, D., Jowett, S., Barton, P., Hodgkinson, J., McManus, R. J., . . . Williams, B. (2011). Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: A modelling study. The Lancet, 378 (9798), 1219-1230. doi:10.1016/S0140-6736(11)61184-7
73.         Williams, B., Lacy, P. S., Yan, P., Hwee, C. N., Liang, C., & Ting, C. M. (2011). Development and validation of a novel method to derive central aortic systolic pressure from the radial pressure waveform using an n-point moving average method. J Am Coll Cardiol, 57 (8), 951-961. doi:10.1016/j.jacc.2010.09.054
74.         Williams, B., Baschiera, F., Lacy, P. S., Papst, C. C., & Brunel, P. (2011). EFFECTS OF EXERCISE ON BRACHIAL SYSTOLIC BLOOD PRESSURE VERSUS CENTRAL AORTIC SYSTOLIC PRESSURE IN PATIENTS WITH HYPERTENSION. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 57 (14), E564.
75.         Doughty, R. N., Whalley, G. A., Gamble, G. D., Walsh, H., Jerums, G., Jacklin, C., . . . Williams, B. (2011). Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: The ADVANCE Echocardiography Substudy. Journal of Hypertension, 29 (7), 1439-1447. doi:10.1097/HJH.0b013e3283480fe9
76.         Krause, T., Lovibond, K., Caulfield, M., McCormack, T., Williams, B., & Grp, G. D. (2011). GUIDELINES Management of hypertension: summary of NICE guidance. BRITISH MEDICAL JOURNAL, 343, ARTN d4891. doi:10.1136/bmj.d4891
77.         Williams, B. (2011). High blood pressure in young people and premature death. BMJ, 342 (7795), 450. doi:10.1136/bmj.d1104
78.         Williams, B. (2011). High blood pressure in young people and premature death Alternative strategies are needed to stratify risk and determine treatment thresholds. BRITISH MEDICAL JOURNAL, 342.
79.         Krause, T., Lovibond, K., Caulfield, M., McCormack, T., & Williams, B. (2011). Management of hypertension: Summary of NICE guidance. BMJ (Online), 343 (7821). doi:10.1136/bmj.d4891
80.         Williams, B., Lacy, P., Yan, P., Chua, N. H., Liang, C., & Ting, C. M. (2011). Reply. Journal of the American College of Cardiology, 58 (16), 1731-1732. doi:10.1016/j.jacc.2011.07.014
81.         Mcmanus, R., Mant, J., Bray, E., Holder, R., Jones, M., Greenfield, S., . . . Hobbs, R. (2010). A RANDOMISED CONTROLLED TRIAL OF TELEMONITORING AND SELF MANAGEMENT IN THE CONTROL OF HYPERTENSION: TELEMONITORING AND SELF MANAGEMENT IN HYPERTENSION (TASMINH2). JOURNAL OF HYPERTENSION, 28, E233.
82.         Jones, M., McManus, R. J., Hobbs, F. D. R., Mant, J., Williams, B., Bryan, S., . . . Virdee, S. (2010). A RANDOMISED CONTROLLED TRIAL OF TELEMONITORING AND SELF MANAGEMENT IN THE CONTROL OF HYPERTENSION: TELEMONITORING AND SELF MANAGEMENT IN HYPERTENSION (TASMINH2): QUALITATIVE STUDY. JOURNAL OF HYPERTENSION, 28, E254.
83.         Williams, B., Baschiera, F., Lacy, P. S., Botha, J., & Brunel, P. (2010). ATTENUATION OF EXERCISE-INDUCED RISE IN SYSTOLIC BLOOD PRESSURE BY THE DIRECT RENIN INHIBITOR ALISKIREN. JOURNAL OF HYPERTENSION, 28, E388.
84.         Williams, B. (2010). BLOOD PRESSURE AND BEYOND: CHOOSING THE OPTIMAL COMBINATION IS A SCIENCE, NOT AN ART. JOURNAL OF HYPERTENSION, 28, E603.
85.         Williams, B., & Lacy, P. S. (2010). Central haemodynamics and clinical outcomes: Going beyond brachial blood pressure?. European Heart Journal, 31 (15), 1819-1822. doi:10.1093/eurheartj/ehq125
86.         Ninomiya, T., Zoungas, S., Neal, B., Woodward, M., Patel, A., Perkovic, V., . . . Williams, B. (2010). Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial. Journal of Hypertension, 28 (6), 1141-1149. doi:10.1097/HJH.0b013e328338a89c
87.         Webb, D. R., Khunti, K., Silverman, R., Gray, L. J., Srinivasan, B., Lacy, P. S., . . . Davies, M. J. (2010). Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia, 53 (6), 1190-1198. doi:10.1007/s00125-010-1689-9
88.         Davies, J. E., Tillin, T., Malaweera, A., Lacy, P. S., Cruickshank, K., Stanton, A., . . . Hughes, A. D. (2010). Pressure-Independent Pulsatility Index (PIPI) Independently Predicts Cardiovascular Events in the Cafe Sub-Study of Ascot. CIRCULATION, 122 (21).
89.         Kaambwa, B., Bryan, S., Mant, J., Bray, E. P., Holder, R., Jones, M., . . . Mcmanus, R. J. (2010). RANDOMISED CONTROLLED TRIAL OF TELEMONITORING AND SELF MANAGEMENT IN THE CONTROL OF HYPERTENSION: TELEMONITORING AND SELF MANAGEMENT IN HYPERTENSION (TASMINH2): ECONOMIC ANALYSIS. JOURNAL OF HYPERTENSION, 28, E281-E282.
90.         McManus, R. J., Bray, E. P., Holder, R., Jones, M. I., Greenfield, S., Kaambwa, B., . . . Williams, B. (2010). Telemonitoring and self-management in the control of hypertension (TASMINH2): A randomised controlled trial. The Lancet, 376 (9736), 163-172. doi:10.1016/S0140-6736(10)60964-6
91.         Chapman, N., Chen, C. -. Y., Fujita, T., Hobbs, F. R., Kim, S. -. J., Staessen, J. A., . . . Williams, B. (2010). Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?. Journal of Hypertension, 28 (9), 1796-1803. doi:10.1097/HJH.0b013e32833b912c
92.         Ninomiya, T., Perkovic, V., De Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., . . . Mancia, G. (2009). Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Journal of the American Society of Nephrology, 20 (8), 1813-1821. doi:10.1681/ASN.2008121270
93.         Williams, B., Lacourcière, Y., Schumacher, H., Gosse, P., & Neutel, J. M. (2009). Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials. J Hum Hypertens, 23 (9), 610-619. doi:10.1038/jhh.2009.4
94.         Williams, B., Lacy, P. S., & Stanley, A. G. (2009). Blood pressure lowering efficacy of direct renin inhibition (aliskiren) in resistant hypertension - an observational study from UK primary care. JOURNAL OF HUMAN HYPERTENSION, 23 (10), 696.
95.         Kengne, A. -. P., Czernichow, S., Huxley, R., Woodward, M., Neal, B., Zoungas, S., . . . Williams, B. (2009). Blood pressure variables and cardiovascular risk: New findings from advance. Hypertension, 54 (2), 399-404. doi:10.1161/HYPERTENSIONAHA.109.133041
96.         Williams, B., & Lacy, P. S. (2009). Central aortic pressure and clinical outcomes. Journal of Hypertension, 27 (6), 1123-1125. doi:10.1097/HJH.0b013e32832b6566
97.         Williams, B. (2009). Hypertension and the "J-curve". J Am Coll Cardiol, 54 (20), 1835-1836. doi:10.1016/j.jacc.2009.06.043
98.         Williams, B., Lacy, P. S., & CAFE and the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators. (2009). Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate. J Am Coll Cardiol, 54 (8), 705-713. doi:10.1016/j.jacc.2009.02.088
99.         Williams, B., Lacy, P. S., Cruickshank, J. K., Collier, D., Hughes, A. D., Stanton, A., . . . CAFE and ASCOT Investigators. (2009). Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study. Circulation, 119 (1), 53-61. doi:10.1161/CIRCULATIONAHA.108.785915
100.       De Galan, B. E., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., . . . Grobbee, D. E. (2009). Lowering blood pressure reduces renal events in type 2 diabetes. Journal of the American Society of Nephrology, 20 (4), 883-892. doi:10.1681/ASN.2008070667
101.       Sleight, P., Redon, J., Verdecchia, P., Mancia, G., Gao, P., Pogue, J., . . . Williams, B. (2009). Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. Journal of Hypertension, 27 (7), 1360-1369. doi:10.1097/HJH.0b013e32832d7370
102.       McManus, R. J., Bray, E. P., Holder, R., Greenfield, S., Jones, M. I., Richard, F. D. R., . . . Williams, B. (2009). Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: Telemonitoring and self-management in hypertension. [ISRCTN17585681]. BMC Cardiovascular Disorders, 9. doi:10.1186/1471-2261-9-6
103.       Williams, B. (2009). Resistant hypertension: an unmet treatment need. Lancet, 374 (9699), 1396-1398. doi:10.1016/S0140-6736(09)61600-7
104.       Redon, J., Sleight, P., Mancia, G., Gao, P., Verdecchia, P., Fagard, R., . . . Yusuf, S. (2009). SAFETY AND EFFICACY OF AGGRESSIVE BLOOD PRESSURE LOWERING AMONG PATIENTS WITH DIABETES: SUBGROUP ANALYSES FROM THE ONTARGET TRIAL. JOURNAL OF HYPERTENSION, 27, S16.
105.       Williams, B. (2009). The Aorta and Resistant Hypertension. Journal of the American College of Cardiology, 53 (5), 452-454. doi:10.1016/j.jacc.2008.10.027
106.       Williams, B. (2009). The changing face of hypertension treatment: Treatment strategies from the 2007 ESH/ESC hypertension Guidelines. Journal of Hypertension, 27 (SUPPL. 3). doi:10.1097/01.hjh.0000356768.24507.69
107.       Williams, B. (2009). The changing face of hypertension treatment: treatment strategies from the 2007 ESH/ESC hypertension Guidelines. J Hypertens Suppl, 27 (3), S19-S26. doi:10.1097/01.hjh.0000356768.24507.69
108.       Zoungas, S., Ninomiya, T., Patel, A., Perkovic, V., Woodward, M., Grobbee, D., . . . Chalmers, J. (2009). THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL. JOURNAL OF HYPERTENSION, 27, S314.
109.       Williams, B. (2009). The year in hypertension. J Am Coll Cardiol, 55 (1), 65-73. doi:10.1016/j.jacc.2009.08.037
110.       Williams, B. (2008). Achieving blood pressure control in clinical practice. Journal of the American Society of Hypertension, 2 (4 SUPPL.). doi:10.1016/j.jash.2008.03.009
111.       Williams, B. (2008). Achieving blood pressure control in clinical practice. J Am Soc Hypertens, 2 (4 Suppl), S10-S15. doi:10.1016/j.jash.2008.03.009
112.       Wilson, W. R. W., Herbert, K. E., Mistry, Y., Stevens, S. E., Patel, H. R., Hastings, R. A., . . . Williams, B. (2008). Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. EUROPEAN HEART JOURNAL, 29 (21), 2689-2694. doi:10.1093/eurheartj/ehn386
113.       Sleight, P., Williams, B., Verdecchia, P., Gao, P., Redon, J., Mancia, G., . . . Yusuf, S. (2008). Blood pressure analyses from 25 595 patients (from 25 620 randomised) during the ONTARGET trial: reflections on current guidelines. JOURNAL OF HUMAN HYPERTENSION, 22 (10), 728.
114.       Bakris, G., Böhm, M., Dagenais, G., Diener, H. -. C., Fujita, T., Gorelick, P., . . . Zannad, F. (2008). Cardiovascular protection for all individuals at high risk: Evidence-based best practice. Clinical Research in Cardiology, 97 (10), 713-725. doi:10.1007/s00392-008-0713-2
115.       Lacy, P. S., & Williams, B. (2008). Impact of heart rate on the differential impact of blood pressure lowering drugs on central and peripheral pressures: Data from the Conduit Artery Function Evaluation (CAFE) study. JOURNAL OF HYPERTENSION, 26, S459.
116.       Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., . . . De Galan, B. E. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358 (24), 2560-2572. doi:10.1056/NEJMoa0802987
117.       Neutel, J. M., Schumacher, H., Gosse, P., Lacourcière, Y., & Williams, B. (2008). Magnitude of the early morning blood pressure surge in untreated hypertensive patients: A pooled analysis. International Journal of Clinical Practice, 62 (11), 1654-1663. doi:10.1111/j.1742-1241.2008.01892.x
118.       Volpe, M., Erhardt, L. R. W., & Williams, B. (2008). Managing cardiovascular risk: The need for change. Journal of Human Hypertension, 22 (2), 154-157. doi:10.1038/sj.jhh.1002273
119.       Williams, B., Lindholm, L. H., & Sever, P. (2008). Systolic pressure is all that matters. Lancet, 371 (9631), 2219-2221. doi:10.1016/S0140-6736(08)60804-1
120.       Williams, B. (2008). The Hypertension in Diabetes Study (HDS): a catalyst for change. Diabet Med, 25 Suppl 2, 13-19. doi:10.1111/j.1464-5491.2008.02506.x
121.       Williams, B. (2008). The year in hypertension. J Am Coll Cardiol, 51 (18), 1803-1817. doi:10.1016/j.jacc.2008.03.010
122.       Williams, B. (2007). beta-blockers and the treatment of hypertension. JOURNAL OF HYPERTENSION, 25 (7), 1351-1353. doi:10.1097/HJH.0b013e328182266a
123.       Williams, B. (2007). Central blood pressure lowering: Implications for clinical outcomes. JOURNAL OF HYPERTENSION, 25, S386.
124.       Agabiti-Rosei, E., Mancia, G., O'Rourke, M. F., Roman, M. J., Safar, M. E., Smulyan, H., . . . Vlachopoulos, C. (2007). Central blood pressure measurements and antihypertensive therapy: A consensus document. Hypertension, 50 (1), 154-160. doi:10.1161/HYPERTENSIONAHA.107.090068
125.       Rodger, R. S. C., & Williams, B. (2007). Consensus conference on early chronic kidney disease - Foreword. NEPHROLOGY DIALYSIS TRANSPLANTATION, 22, 1. doi:10.1093/ndt/gfm439
126.       Lacy, P., Cruickshank, K., Thom, S., Stanton, A., Collier, D., & Williams, B. (2007). Diabetes accentuates the differential impact of blood pressure lowering drugs on central aortic pressure: Principal results from cafe-diabetes; The diabetic cohort within the conduit artery functional evaluation (CAFE) study. JOURNAL OF HYPERTENSION, 25, S279-S280.
127.       Patel, A., MacMahon, S., Chalmers, J., Neal, B., Woodward, M., Billot, L., . . . Williams, B. (2007). Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (London, England), 370 (9590), 829-840. doi:10.1016/s0140-6736(07)61303-8
128.       Puig, J. G., Marre, M., Kokot, F., Fernandez, M., Jermendy, G., Opie, L., . . . Asmar, R. (2007). Efficacy of Indapamide SR Compared With Enalapril in Elderly Hypertensive Patients With Type 2 Diabetes. American Journal of Hypertension, 20 (1), 90-97. doi:10.1016/j.amjhyper.2006.05.018
129.       Messerli, F. H., Williams, B., & Ritz, E. (2007). Essential hypertension. Lancet, 370 (9587), 591-603. doi:10.1016/S0140-6736(07)61299-9
130.       Williams, B. (2007). Hypertension in the young - Preventing the evolution of disease versus prevention of clinical events. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 50 (9), 840-842. doi:10.1016/j.jacc.2007.05.020
131.       Williams, B. (2007). Hypertension in the Young. Preventing the Evolution of Disease Versus Prevention of Clinical Events*Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology, 50 (9), 840-842. doi:10.1016/j.jacc.2007.05.020
132.       Williams, B., & Lacy, P. S. (2007). Impact of heart rate on the differential effect of blood pressure lowering agents on peripheral and central pressures: data from the Conduit Artery Function Evaluation (CAFE) Study. JOURNAL OF HUMAN HYPERTENSION, 21 (10), 836.
133.       Higgins, B., & Williams, B. (2007). Pharmacological management of hypertension. Clinical Medicine, Journal of the Royal College of Physicians of London, 7 (6), 612-616.
134.       Gosse, P., Neutel, J. M., Davidai, G., Schumacher, H., Lacourcière, Y., & Williams, B. (2007). The effect of telmisartan and ramipril on early morning blood pressure surge: A pooled analysis of two randomized clinical trials. Blood Pressure Monitoring, 12 (3), 141-147. doi:10.1097/MBP.0b013e3280b10bbd
135.       Williams, B. (2007). The obese hypertensive: The weight of evidence against β-blockers. Circulation, 115 (15), 1973-1974. doi:10.1161/CIRCULATIONAHA.107.692970
136.       Archibald, G., Bartlett, W., Brown, A., Christie, B., Elliott, A., Griffith, K., . . . Williams, B. (2007). UK consensus conference on early chronic kidney disease - 6 and 7 February 2007. Nephrology Dialysis Transplantation, 22 (9), 2455-2457. doi:10.1093/ndt/gfm268
137.       Williams, B. (2007). β-blockers and the treatment of hypertension. Journal of Hypertension, 25 (7), 1351-1353. doi:10.1097/HJH.0b013e328182266a
138.       Williams, B., Lacy, P. S., Thom, S. M., Cruickshank, K., Stanton, A., Collier, D., . . . CAFE Steering Committee and Writing Committee. (2006). Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation, 113 (9), 1213-1225. doi:10.1161/CIRCULATIONAHA.105.595496
139.       Gosse, R., Schumacher, H., Lacourciere, Y., Neutel, J., & Williams, B. (2006). Effect of patient characteristics on the magnitude of the early morning blood pressure surge. JOURNAL OF HYPERTENSION, 24, S301.
140.       Williams, B. (2006). Evolution of hypertensive disease: a revolution in guidelines. Lancet, 368 (9529), 6-8. doi:10.1016/S0140-6736(06)68943-5
141.       Williams, B. (2006). Hypertension guidelines in the UK: A time for change. British Journal of Cardiology, 13 (4), 233-237.
142.       Williams, B. (2006). Implications and controversies of recent hypertension trials - Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 48 (4), 849-850. doi:10.1016/j.jacc.2006.05.035
143.       Dickinson, H. O., Mason, J. M., Nicolson, D. J., Beyer, F. R., Williams, B., & Ford, G. A. (2006). Lifestyle interventions to reduce raised blood pressure - Reply. JOURNAL OF HYPERTENSION, 24 (10), 2116-2117. doi:10.1097/01.hjh.0000244965.23351.71
144.       Dickinson, H. O., Mason, J. M., Nicolson, D. J., Campbell, F., Beyer, F. R., Cook, J. V., . . . Ford, G. A. (2006). Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials. Journal of Hypertension, 24 (2), 215-223. doi:10.1097/01.hjh.0000199800.72563.26
145.       Lacy, P., Carr, S. J., O'Brien, D., Fentum, B., Williams, B., Paul, S. K., & Robinson, T. G. (2006). Reduced glomerular filtration rate in pre-dialysis non-diabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Clin Sci (Lond), 110 (1), 101-108. doi:10.1042/CS20050192
146.       Dickinson, H. O., Beyer, F. R., Mason, J. M., Nicolson, D. J., Williams, B., & Ford, G. A. (2006). Reply [3]. Journal of Hypertension, 24 (10), 2116-2117. doi:10.1097/01.hjh.0000244965.23351.71
147.       Williams, B., Lacy, P. S., Thurston, H., Thom, S., Hughes, A., Cruickshank, K., . . . O'Rourke, M. (2006). Response to letters regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study" [5]. Circulation, 114 (15). doi:10.1161/CIRCULATIONAHA.106.640870
148.       Williams, B., Gosse, P., Lowe, L., Harper, R., & PRISMA I Study Group. (2006). The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I). J Hypertens, 24 (1), 193-200.
149.       Williams, B. (2006). The year in hypertension. J Am Coll Cardiol, 48 (8), 1698-1711. doi:10.1016/j.jacc.2006.06.074
150.       Stanley, A. G., Swales, P., Thurston, H., & Williams, B. (2006). Treating resistant hypertension in type 2 diabetes: A role for spironolactone?. British Journal of Diabetes and Vascular Disease, 6 (2), 90-92. doi:10.1177/14746514060060020701
151.       Williams, B. (2005). ASCOT - Hold on to your horses!. British Journal of Cardiology, 12 (5), 336-338.
152.       Williams, B., & Lacy, P. S. (2005). Blood pressure and outcomes in clinical trials. J Hypertens, 23 (3), 487-488.
153.       WILLIAMS, B. (2005). Hypertension in Diabetes - Clinical Science to Clinical Practice. 日本内分泌学会雑誌, 81 (1).
154.       Lacy, P., & Williams, B. (2005). Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes - Reply. JOURNAL OF HYPERTENSION, 23 (3), 670-671. doi:10.1097/01.hjh.0000160230.32339.a5
155.       Khoshdel, A. R., Carney, S. L., Lacy, P., & Williams, B. (2005). Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes [3] (multiple letters). Journal of Hypertension, 23 (3), 669-671.
156.       Neutel, J. M., Gosse, P., Schumacher, H., Williams, B., & Lacourciere, Y. (2005). Magnitude of the early morning blood pressure surge in hypertensive patients. AMERICAN JOURNAL OF HYPERTENSION, 18 (5), 39A-40A. doi:10.1016/j.amjhyper.2005.03.107
157.       Neutel, J., Gosse, P., Schumacher, H., Williams, B., & Lacourciere, Y. (2005). Magnitude of the early morning blood pressure surge in hypertensive patients. JOURNAL OF HYPERTENSION, 23, S374.
158.       Williams, B. (2005). Recent hypertension trials: implications and controversies. J Am Coll Cardiol, 45 (6), 813-827. doi:10.1016/j.jacc.2004.10.069
159.       Gosse, P., Neutel, J. M., Schumacher, H., Lacourciere, Y., & Williams, B. (2005). Reduction of early morning blood pressure surge with telmisartan compared with ramipril in mild-to-moderate hypertensive patients. AMERICAN JOURNAL OF HYPERTENSION, 18 (5), 60A. doi:10.1016/j.amjhyper.2005.03.164
160.       Gosse, P., Neutel, J., Schumacher, H., Laccourciere, Y., & Williams, B. (2005). Reduction of early morning blood pressure surge with telmisartan compared with ramipril in mild-to-moderate hypertensive patients. JOURNAL OF HYPERTENSION, 23, S375-S376.
161.       Williams, B., Lacourciere, Y., Schumacher, H., Gosse, P., & Neutel, J. M. (2005). Telmisartan versus ramipril in 24-h ambulatory blood pressure: A pooled analysis of 2 prospective, randomized trials in mild-to-moderate hypertensive patients. AMERICAN JOURNAL OF HYPERTENSION, 18 (5), 76A. doi:10.1016/j.amjhyper.2005.03.209
162.       Williams, B., Lacourciere, Y., Schumacher, H., Gosse, P., & Neutel, J. (2005). Telmisartan versus ramipril in 24-H ambulatory blood pressure: A pooled analysis of 2 prospective, randomized trials in mild-to-moderate hypertensive patients. JOURNAL OF HYPERTENSION, 23, S380.
163.       Mason, J. M., Dickinson, H. O., Campbell, F., Ford, G. A., Nicolson, D. J., & Williams, B. (2005). The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. Journal of Hypertension, 23 (10), 1777-1781.
164.       Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., . . . BHS guidelines working party, for the British Hypertension Society. (2004). British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ, 328 (7440), 634-640. doi:10.1136/bmj.328.7440.634
165.       Marre, M., Puig, J. G., Kokot, F., Fernandez, M., Jermendy, G., Opie, L., . . . Asmar, R. (2004). Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR study. Journal of Hypertension, 22 (8), 1613-1622. doi:10.1097/01.hjh.0000133733.32125.09
166.       Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., . . . British Hypertension Society. (2004). Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens, 18 (3), 139-185. doi:10.1038/sj.jhh.1001683
167.       Williams, B. (2004). Guidelines from the British Hypertension Society - Numbers are missing - Reply. BRITISH MEDICAL JOURNAL, 329 (7465), 570-571. doi:10.1136/bmj.329.7465.570-b
168.       Burns, G. E., Green, P. N., Duerden, M. G., Sackin, P. A., Davies, P., & Williams, B. (2004). Guidelines from the British Hypertension Society [1] (multiple letters). British Medical Journal, 329 (7465), 569-571.
169.       Lacy, P. S., O'Brien, D. G., Stanley, A. G., Dewar, M. M., Swales, P. P., & Williams, B. (2004). Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens, 22 (10), 1937-1944.
170.       Williams, B. (2004). Protection against stroke and dementia: an update on the latest clinical trial evidence. Curr Hypertens Rep, 6 (4), 307-313.
171.       Williams, B. (2004). Pulse wave analysis and hypertension: Evangelism versus scepticism. Journal of Hypertension, 22 (3), 447-449. doi:10.1097/00004872-200403000-00002
172.       Hastings, R., Li, N. C., Lacy, P. S., Patel, H., Herbert, K. E., Stanley, A. G., & Williams, B. (2004). Rapid telomere attrition in cardiac tissue of the ageing Wistar rat. Exp Gerontol, 39 (5), 855-857. doi:10.1016/j.exger.2004.02.003
173.       Williams, B., Wilson, K., Lacey, L., Marchant, N., & Lister, S. (2004). The prevalence and management of patients with co-existing hypertension and hypercholesterolaemia in the UK. EUROPEAN HEART JOURNAL, 25, 528-529.
174.       Williams, B. (2004). VALUE and supremacy of blood pressure control for cardiovascular protection. Journal of Hypertension, 22 (8), 1435-1437. doi:10.1097/01.hjh.0000133749.15985.de
175.       Lasaridis, A. N., Sarafidis, P. A., Williams, B., Julius, S., & McInnes, G. T. (2004). What lies behind the intense criticism of ALLHAT? (multiple letters). Journal of Hypertension, 22 (1), 223-227. doi:10.1097/00004872-200401000-00033
176.       Williams, B., & Poulter, N. (2004). What's new in the new British Hypertension Society guidelines for the management of hypertension - BHS IV. British Journal of Cardiology, 11 (2), 112-117.
177.       Mancia, G., Rosei, E. A., Cifkova, R., DeBacker, G., Erdine, S., Fagard, R., . . . Cardiology, E. S. (2003). 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. JOURNAL OF HYPERTENSION, 21 (6), 1011-1053. doi:10.1097/01.hjh.0000059051.65882.32
178.       Brown, M. J., Cruickshank, J. K., Dominiczak, A. F., MacGregor, G. A., Poulter, N. R., Thom, S., . . . Williams, B. (2003). Better blood pressure control: How to combine drugs. Journal of Human Hypertension, 17 (2), 81-86. doi:10.1038/sj.jhh.1001511
179.       Williams, B. (2003). Drug specific benefits and cardiovascular and stroke outcomes. Journal of Hypertension, 21 (9), 1609-1610. doi:10.1097/00004872-200309000-00002
180.       Williams, B. (2003). Drug treatment of hypertension. British Medical Journal, 326 (7380), 61-62.
181.       Williams, B. (2003). Drug treatment of hypertension - Most patients will need a treatment cocktail-including a thiazide diuretic. BRITISH MEDICAL JOURNAL, 326 (7380), 61-62. doi:10.1136/bmj.326.7380.61
182.       Williams, B. (2003). Drug treatment of hypertension - The future is combination therapy. British Journal of Cardiology, 10 (SUPPL. 3).
183.       Williams, B. (2003). Drug treatment of hypertension: Implications of ALLHAT. Heart, 89 (6), 589-590.
184.       Marre, M., Chastang, C., Ollivier, J. -. P., Asmar, R., Amouyel, P., Puig, J. G., . . . Pozza, G. (2003). Effect of indapamide SR on microalbuminuria - The NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia) - Rationale and protocol for the main trial. Journal of Hypertension, Supplement, 21 (1).
185.       Williams, B. (2003). Treating hypertension: It is not how you start but where you end that matters. Journal of Hypertension, 21 (3), 455-457. doi:10.1097/00004872-200303000-00002
186.       Williams, B. (2003). Treatment of hypertension in the UK: Simple as ABCD?. Journal of the Royal Society of Medicine, 96 (11), 521-522. doi:10.1258/jrsm.96.11.521
187.       Stanley, A. G., O'Brien, D. G., Lacy, P. L., Shiels, A., Thurston, H., & Williams, B. (2002). A novel correction factor for ambulatory blood pressure monitoring in hypertensive subjects. JOURNAL OF HYPERTENSION, 20, S238.
188.       Williams, B. (2002). Angiotensin II receptor antagonism in diabetic education nephropathy: Commentary. Diabetic Medicine, 19 (SUPPL. 3), 10-11.
189.       Swales, P., & Williams, B. (2002). Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension. J Renin Angiotensin Aldosterone Syst, 3 (2), 79-89. doi:10.3317/jraas.2002.022
190.       Redon, J., & Williams, B. (2002). Microalbuminuria in essential hypertension: redefining the threshold. JOURNAL OF HYPERTENSION, 20 (3), 353-355. doi:10.1097/00004872-200203000-00002
191.       Lacy, P. S., O'Brien, D. G., Stanley, A. G., Swales, P. P. R., Carr, S. J., & Williams, B. (2002). Radial artery pulse wave analysis fails to demonstrate increased vascular stiffness in diabetic patients. JOURNAL OF HYPERTENSION, 20, S256.
192.       Bates, D. O., Hillman, N. J., Williams, B., Neal, C. R., & Pocock, T. M. (2002). Regulation of microvascular permeability by vascular endothelial growth factors. JOURNAL OF ANATOMY, 200 (6), 581-597. doi:10.1046/j.1469-7580.2002.00066.x
193.       O'Callaghan, C. J., & Williams, B. (2002). The regulation of human vascular smooth muscle extracellular matrix protein production by α- and β- adrenoceptor stimulation. Journal of Hypertension, 20 (2), 287-294. doi:10.1097/00004872-200202000-00019
194.       Williams, B. (2001). Angiotensin II and the pathophysiology of cardiovascular remodeling. American Journal of Cardiology, 87 (8 SUPPL.).
195.       Williams, B. (2001). Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol, 87 (8A), 10C-17C.
196.       Poulter, N., & Williams, B. (2001). Doxazosin for the management of hypertension: Implications of the findings of the ALLHAT Trial. American Journal of Hypertension, 14 (11 I), 1170-1172. doi:10.1016/S0895-7061(01)02212-9
197.       Poulter, N., & Williams, B. (2001). Doxazosin for the management of hypertension: Implications of the findings of the ALLHAT Trial. AMERICAN JOURNAL OF HYPERTENSION, 14 (11), 1170-1171. doi:10.1016/S0895-7061(01)02212-9
198.       Spratt, J. C. S., Webb, D. J., Shiels, A., & Williams, B. (2001). Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 2 (4), 227-232.
199.       Williams, B., O'Rourke, M., & Anglo-Scandinavian Cardiac Outcomes Trial. (2001). The Conduit Artery Functional Endpoint (CAFE) study in ASCOT. J Hum Hypertens, 15 Suppl 1, S69-S73.
200.       Cappuccio, F. P., Conlon, C. P., John, C. S., Dornhurst, A., Douglas, J. G., Elborn, J. S., . . . Thurston, H. (2001). The ninety-fifth annual general meeting of the association of physicians of Great Britain and Ireland 2001. QJM - Monthly Journal of the Association of Physicians, 94 (11), 643-655.

GMC/GDC number: 2827942